The High Selectivity of the Cp2ZrHCl Reducing Agent for Imides
and the 6-31G** basis set. Solvent effects were modeled by use of
the polarized continuum method (PCM) with adoption of a 7.4257
dielectric constant for THF as implemented in the G09 program.[14]
The geometries were optimized by standard gradient techniques
including solvent effects (B3LYP/6-31G**/PCM=THF) and char-
acterized by evaluation of the Hessian matrix and the associated
harmonic vibrational frequencies. The computed electronic ener-
gies were corrected for zero-point vibrational and thermal energies
and entropies to obtain free energy changes at 298 K (ΔG298).
General Methods: 1H NMR spectra were recorded with Varian
500 MHz spectrometers. Chemical shifts are reported in ppm from
TMS with the solvent resonance as internal standard (deuterio-
chloroform: δ = 7.26 ppm). 13C NMR spectra were recorded with
Varian 500 (125 MHz) spectrometers and with complete proton de-
coupling. Chemical shifts are reported in ppm from TMS with the
34.5, 67.0, 128.0, 129.6, 131.9, 132.9, 168.1 ppm. C10H9NO3
(191.19): calcd. C 62.82, H 4.74, N 7.33; found C 62.83, H 4.73, N
7.32.
NMR Spectroscopic Data for tert-Butyl 3-Hydroxyisoxazolidine-2-
carboxylate (6b): Colorless oil, 95 % yield. 1H NMR (500 MHz,
CDCl3): δ = 1.49 (s, 9 H), 2.23–2.29 (m, 1 H, 4-H) 2.42–2.48 (m, 1
H, 4-H), 3.51–3.57 (m, 1 H, 5-H), 3.71–3.78 (m, 1 H, 5-H), 5.48
(dd, J = 2.5, 6.5 Hz, 1 H, 3-H) ppm. 13C NMR (125 MHz, CDCl3):
δ = 28.2, 36.0, 68.2, 81.8, 82.7, 154.5 ppm. C8H15NO4 (189.21):
calcd. C 50.78, H 7.99, N 7.40; found C 50.79, H 7.98, N 7.41.
NMR Spectroscopic Data for Ethyl 3-Hydroxyisoxazolidine-2-carb-
oxylate (6c): (Colorless oil, 95 % yield). 1H NMR (500 MHz,
CDCl3): δ = 1.32 (t, J = 7.5 Hz, 3 H) 2.95 (ddd, J = 2.2, 7.0,
13.5 Hz, 1 H, 4-H), 2.46–2.51 (m, 1 H, 4-H), 4.0 (dd, J = 8.0,
13.5 Hz, 1 H, 5-H), 4.20–4.23 (m, 1 H, 5-H), 4.25 (q, J = 7.5 Hz, 2
H), 5.78 (dd, J = 2.2, 6.4 Hz, 1 H, 3-H) ppm. 13C NMR (125 MHz,
CDCl3): δ = 14.5, 36.6, 62.7, 68.6, 81.9, 147.0 ppm. C6H11NO4
(161.16): calcd. C 44.72, H 6.88, N 8.69; found C 44.71, H 6.86, N
8.71.
solvent as the internal standard (deuteriochloroform:
δ =
77.0 ppm). All reactions were carried out in flame or oven-dried
glassware under nitrogen with use of standard gastight syringes,
cannulas, and septa unless otherwise noted. THF and toluene were
purified by distillation over sodium and benzophenone. Cp2ZrHCl
and other reagents were purchased and used without further purifi-
cation. Thin-layer chromatographic separations were performed on
silica gel 60-F254 precoated aluminum plates. Preparative separa-
tions were carried out by medium pressure liquid chromatography
(MPLC) on silica gel (0.035–0.070 mm).
Reactions of the Isoxazolidinone Derivatives with Cp2ZrHCl: An
isoxazolidinone derivative (1 mmol) dissolved in toluene or THF
was added under nitrogen to a solution of Cp2ZrHCl in dry toluene
or THF (5 mL) and the mixture was stirred at room temperature.
It was then loaded directly into a short plug of silica gel (ca. 1 g)
and eluted with ethyl acetate, and the eluted solvent was concen-
trated in vacuo. The residue was purified by MPLC.
Synthesis of Compounds
tert-Butyl 3-Oxoisoxazolidine-2-carboxylate (5b): Di-tert-butyl di-
carbonate (2.55 g, 17.23 mmol) was added to a solution of isoxazol-
idin-3-one (1 g, 11.49 mmol) in anhydrous dichloromethane
(15 mL) and triethylamine (2.40 mL, 17.23 mmol). The resulting
mixture was stirred at room temperature for 24 h. The mixture was
concentrated under vacuum and extracted with ethyl acetate (10ϫ
3 mL). Purification by MPLC (cyclohexane/ethyl acetate 7:3) af-
forded the title compound (2.11 g, 98 % yield) as a colorless oil. 1H
NMR (500 MHz, CDCl3): δ = 1.54 (s, 9 H), 2.91 (t, J = 7.5 Hz, 2
H, 4-H) 4.40 (t, J = 7.5 Hz, 2 H) ppm. 13C NMR (75 MHz,
CDCl3): δ = 28.0, 34.4, 68.8, 85.0, 146.3, 167.1 ppm. C8H13NO4
(187.20): calcd. C 51.33, H 7.00, N 7.48; found C 51.34, H 7.00, N
7.49.
Supporting Information (see footnote on the first page of this arti-
cle): Additional NMR figures, characterization of compounds 6b
and 6c, LUMO electron densities of compounds 1b, 2d, 4a, 5d, and
7a and structures for hydrated I-5d-endo-trans-trans intermediate.
Computed geometrical parameters and Cartesian coordinates of
intermediates, transition states, and final products.
Acknowledgments
We thank the Ministero dell’Università e della Ricerca (MIUR),
Messina and Catania Universities and Consorzio Interuniversitario
Nazionale Metodologie e Processi Innovativi di Sintesi (CINMPIS)
for partial financial support and the CINECA Supercomputing
Center for a grant of computer time.
Ethyl 3-Oxoisoxazolidine-2-carboxylate (5c): Ethyl chloroformate
(1.64 mL, 17.23 mmol) was added to a solution of isoxazolidin-3-
one (1 g, 11.49 mmol) in anhydrous dichloromethane (15 mL) and
triethylamine (2.40 mL, 17.23 mmol). The resulting mixture was
stirred at room temperature for 24 h. The mixture was concentrated
under vacuum and extracted with ethyl acetate (10ϫ 3 mL). Purifi-
cation by MPLC (cyclohexane/ethyl acetate 5:5) afforded the title
[1] a) J. T. Spletstoser, J. M. White, A. R. Tunoori, G. I. Georg, J.
Am. Chem. Soc. 2007, 129, 3408–3419; b) J. T. Spletstoser, J. M.
White, G. I. Georg, Tetrahedron Lett. 2004, 45, 2787–2789; c)
J. M. White, A. R. Tunoori, G. I. Georg, J. Am. Chem. Soc.
2000, 122, 11995–11996.
1
compound (1.55 g, 85 % yield) as a white solid, m.p. 61–64 °C. H
[2] B. Ganem, R. R. Franke, J. Org. Chem. 2007, 72, 3981–3987.
[3] V. B. Gondi, K. Hagihara, V. H. Rawal, Chem. Commun. 2010,
46, 904–906.
[4] a) M. Iwata, R. Yazaki, I. Chen, D. Sureshkumar, N. Kumagai,
M. Shibasaki, J. Am. Chem. Soc. 2011, 133, 5554–5560; b) M.
Iwata, R. Yazaki, Y. Suzuki, N. Kumagai, M. Shibasaki, J. Am.
Chem. Soc. 2009, 131, 18244–18245.
[5] a) R. Romeo, S. V. Giofrè, B. Macchi, E. Balestrieri, A. Mas-
tino, P. Merino, C. Carnevale, G. Romeo, U. Chiacchio, Chem-
MedChem 2012, 7, 565–569; b) K. Chioda, J. Shimokawa, T.
Fukuyama, Angew. Chem. Int. Ed. 2012, 51, 2505–2508; c) A.
Piperno, S. V. Giofrè, D. Iannazzo, R. Romeo, G. Romeo, U.
Chiacchio, A. Rescifina, D. G. Piotrowska, J. Org. Chem. 2010,
75, 2798–2805; d) M. A. Arnold, K. A. Day, S. G. Duròn, D. Y.
Gin, J. Am. Chem. Soc. 2006, 128, 13255–13260; e) D. Ian-
nazzo, A. Piperno, V. Pistarà, A. Rescifina, R. Romeo, Tetrahe-
dron 2002, 58, 581–587; f) U. Chiacchio, A. Corsaro, A. Rescif-
NMR (500 MHz, CDCl3): δ = 1.37 (t, J = 7.5 Hz, 3 H), 2.94 (t, J
= 8.0 Hz, 2 H, 4-H), 4.37 (q, J = 7.5 Hz, 2 H), 4.44 (t, J = 8.0 Hz,
2 H, 5-H) ppm. 13C NMR (125 MHz, CDCl3): δ = 14.2, 34.2, 63.8,
67.3, 147.7, 167.1 ppm. C6H9NO4 (159.14): calcd. C 45.28, H 5.70,
N 8.80; found C 45.29, H 5.71, N 8.78.
2-Benzoylisoxazolidin-3-one (7): Benzoyl chloride (2.00 mL,
17.23 mmol) was added dropwise to a solution of isoxazolidin-3-
one (1 g, 11.49 mmol) in anhydrous dichloromethane (15 mL) and
triethylamine (2.40 mL, 17.23 mmol). The resulting mixture was
stirred at room temperature for 24 h. The mixture was concentrated
under vacuum and extracted with ethyl acetate (10ϫ 3 mL). Purifi-
cation by MPLC (cyclohexane/ethyl acetate 5:5) afforded the title
compound (1.75 g, 80 % yield) as a white solid, m.p. 100–106 °C.
1H NMR (500 MHz, CDCl3): δ = 3.0 (t, J = 8 Hz, 2 H, 4-H), 4.55
(t, J = 8 Hz, 2 H, 5-H) ppm. 13C NMR (125 MHz, CDCl3): δ =
Eur. J. Org. Chem. 2013, 95–104
© 2013 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjoc.org
103